Atsushi Kurahashi

Dr. Atsushi Kurahashi

Hakkaisan brewery Co., Ltd.
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Journal of Bioscience and Bioengineering
Verified
Journal Article
Closed access
YOYoshifumi Oguro
Yoshifumi Oguro
TNToshikazu Nishiwaki
Toshikazu Nishiwaki
RSRyota Shinada
Ryota Shinada
KKKazuya Kobayashi
Kazuya Kobayashi
AKAtsushi Kurahashi
Atsushi Kurahashi

1 September 2015 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
HBHema Balakrishna Bhat
Hema Balakrishna Bhat
RIReiko Ishitsuka
Reiko Ishitsuka
TITakehiko Inaba
Takehiko Inaba
MMMotohide Murate
Motohide Murate
MAMitsuhiro Abe
Mitsuhiro Abe
TKToshihide Kobayashi
Toshihide Kobayashi
Ceramide phosphoethanolamine (CPE), a sphingomyelin analog, is a major sphingolipid in invertebrates and parasites, whereas only trace amounts are present in mammalian cells. In this study, mushroom-...

1 October 2013 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
HBHema Balakrishna Bhat
Hema Balakrishna Bhat
TKTakuma Kishimoto
Takuma Kishimoto
MAMitsuhiro Abe
Mitsuhiro Abe
AMAsami Makino
Asami Makino
TITakehiko Inaba
Takehiko Inaba
TKToshihide Kobayashi
Toshihide Kobayashi
A mixture of sphingomyelin (SM) and cholesterol (Chol) exhibits a characteristic lipid raft domain of the cell membranes that provides a platform to which various signal molecules as well as virus and bacterial proteins are recruited. Several proteins capable of specifically binding either SM or Chol have been reported. However, proteins that selectively bind to SM/Chol mixtures are less well characterized. In our screening for proteins specifically binding to SM/Chol liposomes, we identified a novel ortholog of Pleurotus ostreatus, pleurotolysin (Ply)A, from the extract of edible mushroom Pleurotus eryngii, named PlyA2. Enhanced green fluorescent protein (EGFP)-conjugated PlyA2 bound to SM/Chol but not to phosphatidylcholine/Chol liposomes. Cell surface labeling of PlyA2-EGFP was abolished after sphingomyelinase as well as methyl-β-cyclodextrin treatment, removing SM and Chol, respectively, indicating that PlyA2-EGFP specifically binds cell surface SM/Chol rafts. Tryptophan to alanine point mutation of PlyA2 revealed the importance of C-terminal tryptophan residues for SM/Chol binding. Our results indicate that PlyA2-EGFP is a novel protein probe to label SM/Chol lipid domains both in cell and model membranes.

4 August 2016 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
AMAsami Makino
Asami Makino
MAMitsuhiro Abe
Mitsuhiro Abe
RIReiko Ishitsuka
Reiko Ishitsuka
MMMotohide Murate
Motohide Murate
TKTakuma Kishimoto
Takuma Kishimoto
TKToshihide Kobayashi
Toshihide Kobayashi
We identified a novel, nontoxic mushroom protein that specifically binds to a complex of sphingomyelin (SM), a major sphingolipid in mammalian cells, and cholesterol (Chol). The purified protein, termed nakanori, labeled cell surface domains in an SM‐ and Chol‐dependent manner and decorated specific lipid domains that colocalized with inner leaflet small GTPase H‐Ras, but not K‐Ras. The use of nakanori as a lipid‐domain–specific probe revealed altered distribution and dynamics of SM/Chol on the cell surface of Niemann‐Pick type C fibro‐blasts, possibly explaining some of the disease phenotype. In addition, that nakanori treatment of epithelial cells after influenza virus infection potently inhibited virus release demonstrates the therapeutic value of targeting specific lipid domains for anti‐viral treatment. —Makino, A., Abe, M., Ishitsuka, R., Murate, M., Kishimoto, T., Sakai, S., Hullin‐Matsuda, F., Shimada, Y., Inaba, T., Miyatake, H., Tanaka, H., Kurahashi, A., Pack, C.‐G., Kasai, R. S., Kubo, S., Schieber, N. L., Dohmae, N., Tochio, N., Hagiwara, K., Sasaki, Y., Aida, Y., Fujimori, F., Kigawa, T., Nishibori, K., Parton, R. G., Kusumi, A., Sako, Y., Anderluh, G., Yamashita, M., Kobayashi, T., Greimel, P., Kobayashi, T. A novel sphingomyelin/cholesterol domain‐specific probe reveals the dynamics of the membrane domains during virus release and in Niemann‐Pick type C. FASEB J . 31, 1301–1322 (2017) www.fasebj.org

10 June 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
AKAtsushi Kurahashi
Atsushi Kurahashi
The sweet drink amazake is a fermented food made from Aspergillus oryzae and related koji molds in Japan. There are two types of drinks called amazake, one made from koji (koji amazake) and the other made from sake lees, a by-product of sake (sakekasu amazake). The sweetness of koji amazake is from glucose, derived from starch broken down by A. oryzae amylase. The other, sakekasu amazake, depends on added sugar. The main components are glucose and sucrose, but they also contain more than 300 other ingredients. Koji amazake contains oligosaccharides and ergothioneine, and sakekasu amazake has a resistant protein and α-ethyl glucoside, which are characteristic ingredients of each amazake. However, there are also common ingredients such as glycosylceramide. Functionality is known to include anti-fatigue, bowel movement, skin barrier, and other effects on human health. In particular, the bowel movement-improving effects have been well studied for both amazakes. These functions result from ingesting approximately 100 mL per day, but human clinical trials have clarified that this amount has no effect on blood glucose levels and weight gain. In the future, the identification of substances associated with each function is required.

1 May 2019 in Journal of Bioscience and Bioengineering
Verified
Journal Article
Closed access
YOYoshifumi Oguro
Yoshifumi Oguro
ANAyana Nakamura
Ayana Nakamura
AKAtsushi Kurahashi
Atsushi Kurahashi